Alembic Pharma Receives USFDA Approval for Haloperidol Tablets Kumar Jeetendra | June 5, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Haloperidol Tablets, USP, 1 mg, 2 mg, 5 mg, 10 mg, and 20 mg. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Haldol …
Aragen to Manufacture Renaissance Pharma’s Fast-Track mAb Kumar Jeetendra | June 3, 2026 Aragen, a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), has successfully tech-transferred and manufactured the first commercial-scale GMP batches of Renaissance Pharma’s lead candidate, Daretabart – a humanized monoclonal antibody targeting GD2 for high-risk neuroblastoma – in just 9 months. The anti-GD2 monoclonal antibody received Fast Track Designation from the FDA in April 2026 for …
Cipla Launches First-of-its-kind Sputum Inflammometry Lab Kumar Jeetendra | June 3, 2026 Cipla Limited today announced the launch of a first-of-its-kind Sputum Inflammometry Lab at the Breathefree Lung Wellness Center (BLWC) in Mumbai, marking the advancement of precision respiratory diagnostics and integrated respiratory care in the country. The lab was inaugurated by Dr. Parameswaran Nair, globally recognised as one of the pioneers and leading experts in the …
Alembic Pharma Wins USFDA Approval for Dapagliflozin Tablets Kumar Jeetendra | April 7, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Dapagliflozin Tablets, 5 mg and 10 mg. Alembic Pharmaceuticals Limited Gets USFDA Approval for Dapagliflozin Tablets The approved ANDA is therapeutically equivalent to the reference listed drug product …
Conflict to Capsules: Pharma Feels the Heat Kumar Jeetendra | March 31, 2026 The sustained tensions between Iran and the United States since 2026 have become increasingly severe, with impacts beyond military engagements, including an expansive global economic impact, and an effect on Asia’s pharmaceuticals industry, which is now one of the most impacted. The Global Economic Impact of the War The war has impacted one of the …
Alembic Pharma Gets USFDA Approval for Paroxetine ER Tablets Kumar Jeetendra | March 30, 2026 Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from the US Food & Drug Administration (USFDA) for its supplemental Abbreviated New Drug Application (sANDA) Paroxetine Extended-Release Tablets USP, 12.5 mg. The approved sANDA is therapeutically equivalent to the reference listed drug product (RLD), Paxil CR Tablets, 12.5 mg, of Apotex Inc. …
Mettler-Toledo to Showcase Product Inspection Innovations at Interpack 2026 Kumar Jeetendra | February 9, 2026 Giesen, Germany. 26 January 2026 – At Interpack 2026, Mettler-Toledo Product Inspection (Hall 11 Stand A60), a global leader in precision instruments and inspection solutions, will demonstrate how manufacturers can inspect every product with confidence, protect brands and profits, and comply with evolving regulatory requirements, under the theme “Inspect. Protect. Comply.” Visitors from the food, …
Top 10 Pharma Companies Shaping India’s Healthcare (2026) Kumar Jeetendra | January 21, 2026 India is one of the largest centers of global pharmaceutical manufacturers, who supply cost effective and high quality medicines. The majority of Indian pharmaceutical manufacturers produce and market generics, active pharmaceutical ingredients (APIs), biosimilars and specialty therapies which foster progressive and affordable healthcare. Regarding the elements of company profile market standing, production potential, research and …
Top 10 Trends Driving Lab, Pharma & Biopharma in 2026 Kumar Jeetendra | January 20, 2026 Advancements in technology, changes in regulatory frameworks, a growing emphasis on sustainable practices, and the need for innovation are reshaping the laboratory, pharmaceutical, and biopharmaceutical sectors. Through the lens of Industry Adoption, Impacts, and Relevance to the Indian and Global Markets, Microbioz India examines the trends with the highest magnitude of change. Rank 1: Automation …
Ami Polymer launches IMAFLEXELL™ Film for bioprocessing applications Kumar Jeetendra | December 8, 2025 In today’s rapidly evolving bioprocessing landscape, maintaining uncompromised sterility, safety, and performance has become more critical than ever. Addressing these demands, Ami Polymer Pvt. Ltd. introduces IMAFLEXELL™ Film, a next-generation multi-layer barrier film engineered to elevate the reliability of single-use bioprocessing systems. What Makes IMAFLEXELL™ Film Unique Ami Polymer Pvt Ltd. has engineered Imaflexell™ Film, …
Microbioz India to Host Live Webinar on Injection Molding for Pen & Auto-Injectors Kumar Jeetendra | December 8, 2025 Delhi, India | December 2025 — Microbioz India, a leading B2B media platform for the pharma, biopharma, and medical technology industries, is set to host a live, knowledge-driven webinar titled: “Meeting Injection Molding Demand for Pen and Auto-Injectors in Modern Healthcare” Date: 25th February 2026 Time: 3:00 PM IST Speaker: Hiren Khatri, Regional Manager – …
Shilpa Medicare Opens Flow Chemistry Manufacturing Centre Kumar Jeetendra | November 1, 2025 Shilpa Medicare – the full-service contract development and manufacturing organization (CDMO) – announces the launch of its new flow chemistry Centre of Excellence (CoE) at CPHI Frankfurt. Based at the CDMO’s Bangalore site, the Centre unites cross-functional teams across R&D and manufacturing to accelerate process development, scale-up, and commercial production for continuous flow. The new CoE is staffed by a team of more than 100 …
